Green Farmers

Did You Know? Cannabis Affects Everyone Differently. Cannabis doesn’t work the same way for everyone. Its effects depend on a variety of factors, including: 🌱 Your Endocannabinoid system: This natural system is unique to each person and interacts with cannabinoids differently. 🍃 The THC-to-CBD ratio in the product: These compounds influence how the body responds, with varying effects on mood, pain, and more. 🌿 Individual factors: Age, genetics, health conditions, and previous cannabis exposure can all play a role in shaping your experience. These differences highlight the importance of personalised guidance when considering cannabis use. Always consult a doctor or healthcare professional to determine what might be suitable for your circumstances and needs. #CannabisEducation #EndocannabinoidSystem #PersonalisedCare #CannabisAwareness #MedicalCannabis #AustralianCannabis

A Closer Look at CBC 🌿🧬 Cannabichromene (CBC) is a non-psychoactive cannabinoid found in the cannabis plant. While it doesn’t bind strongly to CB1 or CB2 receptors, research suggests CBC plays a role in the entourage effect, potentially enhancing the therapeutic benefits of other cannabinoids and terpenes. How CBC Works: CBC interacts with TRPV1 and TRPA1 receptors, which are associated with pain perception and inflammation. These interactions make CBC an area of growing interest in cannabinoid research. Research Areas: CBC is being studied for its potential role in reducing inflammation and supporting neuroprotection. Its ability to complement other cannabinoids further underscores its importance in full-spectrum cannabis products. Why Understanding CBC Matters for Patient Care: For healthcare providers, understanding CBC’s role in the entourage effect can help them optimise medicinal cannabis treatments by harnessing the combined benefits of cannabinoids and terpenes. Patients, too, can benefit from learning how cannabinoids like CBC contribute to a holistic therapeutic approach. For more information on cannabinoids and the ECS, visit the University of Sydney's Lambert Initiative for Cannabinoid Therapeutics: https://lnkd.in/g8-JyF5y Source: Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.British Journal of Pharmacology, 163(7), 1344-1364. #CBC #Cannabinoids #EndocannabinoidSystem #MedicinalCannabis #PatientCare #GreenFarmers #HealthcareEducation

Trials for the first batch of Apollo Green genetics have begun at Green Farmers’ Victorian facility, including the highly anticipated OG Triploid from Humboldt Seed Company. These advanced genetics offer increased yield potential, trichome density, and uniformity—empowering Australian growers to raise cultivation standards and improve patient outcomes. With Apollo Green, a wholly owned subsidiary of Biortica Agrimed, we’re proud to bring world-class genetics to Australia’s medicinal cannabis industry Learn more: https://lnkd.in/gRnGapY7 #MedicinalCannabis #HumboldtSeedCo #BiorticaAgrimed #GreenFarmers #ApolloGreen #CannabisGenetics #Triploids #CannabisGenetics

A Closer Look at CBDV 🌿🧬 Cannabidivarin (CBDV) is a non-intoxicating cannabinoid closely related to CBD. While it shares structural similarities with CBD, CBDV exhibits distinct properties that make it a focus of increasing research. Early studies have highlighted its potential in addressing neurological conditions and epilepsy, showcasing the diverse therapeutic possibilities within cannabis compounds. How CBDV Works: CBDV interacts with the endocannabinoid system (ECS) indirectly, influencing receptors involved in neurological processes and modulation of seizure activity. Research Areas: Current studies are exploring CBDV’s potential in managing epileptiform activity and other neurological conditions. As research expands, CBDV’s unique profile continues to highlight the therapeutic diversity of cannabinoids. Why Understanding CBDV Matters for Patient Care: For healthcare providers, understanding CBDV’s distinct properties offers an opportunity to expand personalised medicinal cannabis treatment options. Patients can benefit from learning how cannabinoids like CBDV contribute to a broader understanding of cannabis-based therapies. For more information on cannabinoids and the ECS, visit the University of Sydney's Lambert Initiative for Cannabinoid Therapeutics: https://lnkd.in/g8-JyF5y #CBDV #Cannabinoids #EndocannabinoidSystem #MedicinalCannabis #PatientCare #GreenFarmers #HealthcareEducation

There are some hot topics up for debate in the cannabis industry, where legacy lore and medicinal practices can sometimes contradict one another. Traditional growing methods and modern medicinal standards don’t always align, but that’s where real progress begins. At Green Farmers, we want to encourage these important discussions. We believe that by bridging the gap between the legacy world and today’s medicinal standards, we can foster an approach that leads to better-quality medicine for Australian patients. By embracing both experience and evidence, we can shape the future of medicinal cannabis in a way that respects the past while pushing forward toward better outcomes for patient care. #CannabisIndustry #BridgingTheGap #MedicinalCannabis #LegacyCannabis #PatientCare #CannabisCultivation #GrowWithGF

A Closer Look at THCV 🌿🧬 Tetrahydrocannabivarin (THCV) is a unique cannabinoid with a chemical structure similar to THC but offering distinct effects. Unlike THC, THCV acts as an antagonist at CB1 receptors in low doses, meaning it may counteract some of the psychoactive effects of THC. At higher doses, THCV is believed to act as a CB1 receptor agonist, potentially mimicking THC’s effects but with a shorter duration. How THCV Works: At low doses, THCV blocks CB1 receptor activity, which has sparked interest in its potential role in appetite suppression and metabolic regulation. At higher doses, its behaviour shifts to activate these receptors, producing effects more similar to THC. Research Areas: THCV is currently being studied for its potential applications in areas such as metabolic health, neurological conditions, and anti-inflammatory treatments. As with all cannabinoids, it’s essential for patients to consult healthcare professionals before considering THCV as part of their treatment plan. Why Understanding THCV Matters for Patient Care: Healthcare providers can use their understanding of THCV’s unique receptor interactions to develop more tailored medicinal cannabis treatments. For patients, learning about THCV’s distinct properties expands their knowledge of how cannabinoids may address specific health needs. (This information is for educational purposes only). Sources: Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199-215. #THCV #Cannabinoids #EndocannabinoidSystem #MedicinalCannabis #PatientCare #GreenFarmers #HealthcareEducation

Cannabis has transformed significantly over the centuries. Historically, strains were naturally lower in THC and richer in other cannabinoids like CBD. These balanced profiles were key to their use in traditional medicine and cultural practices. Today, particularly in adult-use markets, high THC content has become the focus. But is more THC always better? While THC contributes to cannabis’ effects, an emphasis on potency alone risks overlooking the broader benefits of a balanced cannabinoid profile. Research supports the entourage effect—where cannabinoids and terpenes work together—to deliver more personalised and effective outcomes. In Australia’s medicinal cannabis industry, we believe it’s crucial to prioritise formulations that focus on patient health, safety, and holistic benefits rather than just potency. What are your thoughts? #MedicinalCannabis #CannabisEvolution #PatientCare #EntourageEffect #CannabinoidScience #CannabisIndustry #CannabisResearch

A Closer Look at CBG 🌿🧬 Cannabigerol (CBG) is a non-psychoactive cannabinoid often referred to as the "mother of all cannabinoids" because it serves as a precursor to other cannabinoids, including THC, CBD, and CBC. Although found in smaller quantities in most cannabis strains, CBG’s unique properties make it an important focus of research. How CBG Works: CBG interacts with both CB1 and CB2 receptors in the endocannabinoid system (ECS), though not as strongly as THC. It also binds to other receptors, such as alpha-2 adrenergic receptors and serotonin receptors, which play a role in regulating pain and mood. Research Areas: CBG is being studied for its potential anti-inflammatory and neuroprotective properties, as well as its potential role in supporting eye health. As with other cannabinoids, patients should consult with healthcare professionals before considering CBG as part of their treatment plan. Why Understanding CBG Matters for Patient Care: Healthcare professionals can use their knowledge of how CBG interacts with the ECS to tailor personalised treatment plans. For patients, learning about CBG and its unique properties provides a broader understanding of how medicinal cannabis can be customised to meet specific health needs. (This information is for educational purposes only). Sources: https://lnkd.in/g9hEmYFS  https://lnkd.in/g8-JyF5y #CBG #Cannabinoids #EndocannabinoidSystem #MedicinalCannabis #PatientCare #GreenFarmers #HealthcareEducation

The pain of importing medicinal cannabis may soon be over. As Australian cultivators continue to evolve, we’re producing high-quality medicine right here at home—featuring iconic genetics from California’s finest, including Purple City Genetics (PCG) and Humboldt Seed Company. This means fresher, faster medicine for Australian patients and opens the door for Australian exports, boosting our industry. Not only will this reduce reliance on imports, but it will also create jobs and support the local economy. Through refining cultivation techniques and adopting world-class genetics, Australian growers are sowing the seeds for a future where locally grown medicinal cannabis meets patient needs without the need for international sources. The future of Australian-grown medicine is bright—fuelled by innovation, rooted in global expertise, and built for the benefit of Australian patients. #MedicinalCannabis #AustralianGrown #CannabisCultivation #PurpleCityGenetics #HumboldtSeedCo #GreenFarmers #PatientCare

Tip burn—those brown, crispy edges on leaves—is a common sign that your cannabis plants are stressed. Often caused by nutrient imbalances or environmental factors, tip burn can negatively impact plant health and yield. Here’s how to prevent it: 🌱 Nutrient Management: Overfeeding your plants, particularly with nitrogen or other nutrients, is one of the main causes of tip burn. Carefully monitor and adjust your nutrient levels to avoid excesses. 🍃 Environmental Control: High temperatures and low humidity can exacerbate tip burn. Ensure your grow room, glass house, or outdoor setup maintains the right humidity and temperature balance to prevent stress on your plants. 🌿 Watering Practices: Inconsistent watering or water with high mineral content can contribute to tip burn. Always check your water quality and maintain a consistent watering schedule to keep your plants healthy. Fear not—a little bit of tip burn isn’t always a bad thing. In fact, for some cultivars, mild stress can improve plant performance. The key is to find the right balance, and in certain strains, a bit of tip burn can indicate you're pushing them just enough to maximise yield and potency. #CannabisCultivation #TipBurn #HealthyPlants #NutrientManagement #CannabisCultivars #GreenFarmers #MedicinalCannabis #GrowWithGF